1-6 of 6
Timothy S Bailey
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The SimpliciT1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Adaptive Study of TTP399, a Hepatoselective Glucokinase Activator, for Adjunctive Treatment of Type 1 Diabetes

Free
Klara R. Klein, Jennifer L.R. Freeman, Imogene Dunn, Chris Dvergsten, M. Sue Kirkman, John B. Buse, Carmen Valcarce, SimpliciT1 research group, John B. Buse, Klara R. Klein, M. Sue Kirkman, Katherine A. Bergamo, Elizabeth H. Harris, Jean M. Dostou, Laura A. Young, Sriram Machineni, Alex M. Kass, Jamie C. Diner, Milana Dezube, Virginia C. Purrington, Julie M. Uehling, Rachael M. Fraser, Katherine R. Schuch, Jennifer V. Rowell, Ali Qamar, K. Jean Lucas, Luke Snedaker, Stephanie Hoover, Justin Smith, Paul Becton, Jeffrey Hainsworth, Timothy S. Bailey, Juan Pablo Garcia-Naranjo, Niki Nguyen, Bruce W. Bode, Jennifer M. Boyd, Betsy Childs, Pablo Mora, Allison Camacho, Carl D. Vance, Karen Lugo, Anuj Bhargava, Kirstie Stifel, Lisa B. Connery, Birjis Khan, Simone D. Smith, John Parker, Kathryn Zweier, Emily Kronenfeld, Brittany Savoca, Viral N. Shah, Prakriti Joshee, Shivani Dixit, Hal Joseph, Halis Kaan Akturk, Subbulaxami Trikudanathan, Dori Khakpour, Julia Chang, Anne Peters, Pejman Cohan, Mark Harmel, Wendy S . Lane
Journal: Diabetes Care
Diabetes Care 2021;44(4):960–968
https://doi.org/10.2337/dc20-2684
Published: 23 February 2021
View articletitled, The SimpliciT1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Adaptive Study of TTP399, a Hepatoselective Glucokinase Activator, for Adjunctive Treatment of Type 1 Diabetes
Open the PDF for The SimpliciT1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Adaptive Study of TTP399, a Hepatoselective Glucokinase Activator, for Adjunctive Treatment of Type 1 Diabetes in another window
Journal Articles

Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study

Free
John B. Buse, Satish K. Garg, Julio Rosenstock, Timothy S. Bailey, Phillip Banks, Bruce W. Bode, Thomas Danne, Jake A. Kushner, Wendy S. Lane, Pablo Lapuerta, Darren K. McGuire, Anne L. Peters, John Reed, Sangeeta Sawhney, Paul Strumph
Journal: Diabetes Care
Diabetes Care 2018;41(9):1970–1980
https://doi.org/10.2337/dc18-0343
Published: 24 June 2018
View articletitled, Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study
Open the PDF for Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study in another window
Includes: Supplementary data
Journal Articles

Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors

Free
David C. Klonoff, Joan Lee Parkes, Boris P. Kovatchev, David Kerr, Wendy C. Bevier, Ronald L. Brazg, Mark Christiansen, Timothy S. Bailey, James H. Nichols, Michael A. Kohn
Journal: Diabetes Care
Diabetes Care 2018;41(8):1681–1688
https://doi.org/10.2337/dc17-1960
Published: 13 June 2018
View articletitled, Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors
Open the PDF for Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors in another window
Includes: Supplementary data
Journal Articles

Comparison of Insulin Glargine 300 Units/mL and 100 Units/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections

Free
Richard M. Bergenstal, Timothy S. Bailey, David Rodbard, Monika Ziemen, Hailing Guo, Isabel Muehlen-Bartmer, Andrew J. Ahmann
Journal: Diabetes Care
Diabetes Care 2017;40(4):554–560
https://doi.org/10.2337/dc16-0684
Published: 23 January 2017
View articletitled, Comparison of Insulin Glargine 300 Units/mL and 100 Units/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections
Open the PDF for Comparison of Insulin Glargine 300 Units/mL and 100 Units/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections in another window
Includes: Supplementary data
Journal Articles

Combination Therapy for NIDDM With Biosynthetic Human Insulin and Glyburide

Free
Nicholas H E Mezitis, MD, Stanley Heshka, PHD, Valerie Saitas, MD, Timothy S Bailey, MD, Rafaella Costa, MD, F Xavier Pi-Sunyer, MD
Journal: Diabetes Care
Diabetes Care 1992;15(2):265–269
https://doi.org/10.2337/diacare.15.2.265
Published: 01 February 1992
View articletitled, Combination Therapy for NIDDM With Biosynthetic Human Insulin and Glyburide
Open the PDF for Combination Therapy for NIDDM With Biosynthetic Human Insulin and Glyburide in another window
Journal Articles

Combination Therapy With Insulin and Sulfonylureas for Type II Diabetes

Free
Timothy S Bailey, MD, Nicholas H E Mezitis, MD
Journal: Diabetes Care
Diabetes Care 1990;13(6):687–695
https://doi.org/10.2337/diacare.13.6.687
Published: 01 June 1990
View articletitled, Combination Therapy With Insulin and Sulfonylureas for Type II Diabetes
Open the PDF for Combination Therapy With Insulin and Sulfonylureas for Type II Diabetes in another window